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factors. RR of CV events is shown in the table. 
Conclusion: Current ERT use among older women was associated with fewer myocardial 
infarctions and "HERS endpoints", but there was no association with all cause mortality 
or stroke. Past ERT use was associated with lower all cause mortality, but there was no 
association with CV events. The observed associations may reflect a healthy-user effect. 
Clinical trials will be necessary to assess the effect of ERT in older women. 
Fully Adjusted Cox Model of CV Events (RR(95%Cl)) 
Past ERT Current ERT 
Death .72 (.57,.90) 1.03 (.76,1.40) 
Myocardial Infarction ,90 (,66,1.23) .44 (.23,.84) 
Stroke ,84 (.62,1,13) .94 (.60,1.45) 
"HERS Endpoint" (nonfatal MI or CHD death) .82 (.64,1.06) .54 (.34.86) 
1113-150 Chron ic  V i tamin C Supplementation Improves 
Endothelial Function in Diabetic Pat ients  With Coronary  
Ar tery  Disease 
Charalambos Antoniades. Dimltris Tousoulis, Costas Tentolouris, Kyriakoula Marinou, 
Athanasios Trikas, Stella Brilii, Christos Pitsavos. Christodoulos Stefanadis, Pavlos 
Toutouzas, Cardiology Unit, Hippokration Hospital, Athens University Medical School, 
Athens, Greece. 
Background: Coronary artery disease (CAD) as well as diabetes mellltus (DM), are both 
known to be associated with endothelial dysfunction. Oxidative stress is considered to be 
one of the most important mechanisms involved in the pathogenesis of endothelial dysfunc- 
tion in CAD and DM. In this study we investigated whether treatment with the antioxidant 
vitamin C improves endothelial function in patients with type ~ or II DM and CAD. 
Methods: In a double-blind placebo-controlled study, 48 patients (42 males, 6 females, aged 
66±1.3 years) with CAD and DM, were enrolled. 22 of them were of type I DM and 26 of type 
I1.18 diabetic patients (7 with type I DM (group A) and 11 with type II DM (group B)) were 
treated with vitamin C 2g/day for 4 weeks. The remaining (15 with type I DM (group C) and 
15 with type II DM (group D)) received placebo for 4 weeks. Forearm blood flow was mea- 
sured using venous occlusion strain-gauge plethysmography, at baseline and after treat- 
ment. Endothelium dependent flow mediated vasodilation (FMD) was expressed as the % 
change from baseline to post reactive hyperemia blood flow. Endothelium independent flow 
(NTG%) was expressed as the % change from baseline to pest sublingual nitroglycerin 
administration flow. 
Results: Baset blood pressure, heart rate, body weight, basal forearm blood flow and NTG% 
remained unchanged in all groups. All values are expressed as msan±SEM. FMD was sim- 
ilar between patients with type I (53.9±3.3%) and type II (57.8±6.0%, p=NS) DM. After treat- 
ment, RH% was significantly increased in groups A (from 54.2±7.3 to 73.1±7.1% p<0.05) 
and B (from 66.5±11.7 to 84.3±15.1% p<0.05) while remained unchanged in groups C (from 
53.1 ±4.2 to 50,1 ±8.2% p=NS) and D (from 55.8±11.6 to 58.3±10.1% p=NS). 
Conclusions: Chronic administration of vitamin C seems to improve endothelial function in 
patients with combined coronary artery disease and diabetes mellitus of type I or II. These 
findings indicate a possible beneficial role of antioxidant vitamin C in diabetic patients with 
coronary artery disease. 
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830FO-2 The Yield of  Screening Stress Myocardial Perfusion 
Imaging in Asymptomatic Diabetics 
Todd D. Miller. Navin Rajagopalan, David O. Hodge, Robert L Frye, Raymond J. 
Gibbons, Mayo Clinic, Rochester, Minnesota. 
Background: Diabetics have a higher prevalence of silent coronary artery disease 
(CAD) than nondiabetics and a prognosis similar to that of patients with established CAD. 
Nonetheless, screening stress testing in asymptomatic persons without known CAD 
including diabetics is not well established according to the ACC/AHA Guidelines for Exer- 
cise Testing. 
Methods: The results of exercise and pharmacologic single photon emission computed 
tomography (SPECT) imaging were analyzed in 27,179 patients without known CAD who 
underwent testing between January 1986 and December 2000. Patients were grouped 
by symptom and diabetes status. SPECT scans were categorized as abnormal or not 
and "high-dsk" (on the basis of previously published critaria) or not. 
Results: 
Subset Number Age Male (%) Abnormal High-risk 
(yrs_+ SD) SPECT (%) SPECT (%) 
Symptomatic, nondiabetic 16,196 62_+15" 53* 44* 13" 
Symptomatic, diabetic 2994 63_+11" 53* 59 22 
Asymptomatic, nondiabetic 6248 63_+11 * 73* 46* 11 * 
Asymptomatic, diabetic 1741 60~__13 70 59 20 
• p _< 0.004 vs asymptomatic diabetic 
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Insulin use did not further stratify asymptomatic diabetics for abnormal SPECT (57% 
insulin vs 60% no insulin, p=0.15) or high-dsk SPECT images (20% insulin vs 19% no 
insulin, p=0,59). In asymptomatic diabetics who underwent exercise stress (52%), a pos- 
itive ECG occurred in 29%. 
Conclusions: In asymptomatic patients referred for screening stress SPECT imaging, 
diabetics are slightly younger and more frequently female than nondiabetics but have a 
significantly higher prevalence of abnormal and high-risk SPECT scans. Both abnormal 
and high-risk scans are more common in asymptomatic diabetics than even in symptom- 
atic nondiabetics. 
2:30 p.m. 
830FO-3 Compar i son  of  Noninvaslve Cardiac Testing in 903 
Asymptomatic Men: Corre lat ion With Coronary  
Angiography and With Cl inical  Events  st  Two and Five 
Years 
Patrick J. Fitzsimmons. Ants Palm-Leis, William T. Thompson, William B. Kruyer, USAF 
School of Aerospace Medicine, Brooks AFB, Texas. 
Background: Noninvasive techniques may be used to screen asymptomatic subjects for 
coronary artery disease (CAD). However, the accuracy of these tests is significantly influ- 
enced by the low prevalence of CAD in asymptomatic populations. We sought to define 
the accuracy of three noninvasive tests for predicting significant CAD and cardiac events 
in a population of asymptomatic men. 
Methods: From a database of 1487 asymptomatlc military aviators who had coronary 
angiography performed for occupational indications and had clinical follow-up, we identi- 
fied 903 who had all three noninvasive tests prior to angiography - treadmill, stress thal- 
lium imaging and coronary artery fluoroscopy for detection of coronary calcification. 
Sensitivity, specificity and positive and negative predictive values were calculated for 
each test for the presence of significant CAD (maximum lesion >50% stenosis). Cardiac 
event rates at two and five years were determined for abnormal versus normal test. Car- 
diac events considered were cardiac death, nonfatal myocardial infarction and coronary 
revascularization. 
Results: Mean age at coronary angiography was 43.7 (+/-6.2) years and mean follow-up 
was 11.8 (+/-3.8) years. Sensitivity, specificity and positive and negative predictive values 
for the presence of significant CAD were: treadmill 54%, 49%, 16% and 86%; thallium 
55%, 62%, 21% and 89%; and fluoroscopy 68%, 71%, 29% and 93%. Average annual 
cardiac event rates at two and five years for abnormal test were: abnormal treadmill 
1.0%/yr and 0.5%/yr, abnormal thanium 1.0%/yr and 0.6% /yr, and positive coronary 
artery fluoroscopy 1.6%/yr and 1.3%/yr. For normal test, event rates at two and five years 
were: normal treadmill 0.3%/yr and 0.5%/yr, normal thanium 0.5%/yr and 0.5%/yr, and 
negative fluoroscopy 0.2%/yr and 0.1%/yr, 
Conclusion: As expected, all three noninvasive tests were independently poor predictors 
of significant CAD and cardiac events in this low CAD prevalence population. For all 
parameters examined, detection of coronary calcification by routine fluoroscopy per- 
formed better than treadmill and thallium, both for prediction of anatomic disease and for 
cardiac events at two and five years of fonow-up. 
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830FO-4 Ventrlcular Ectopic Activity Predicts Mortality When It 
Occurs During Recovery, but Not Just During Exercise 
Joseph Frolkis, Claire E. Pothier Snarler, Eugene H. Blackstone, Michael S. Lauer. 
Cleveland Clinic Foundation, Cleveland, Ohio. 
Background: Ventdcular ectopy (VEA) induced by exercise predicts death in population- 
based cohorts. We examined the prognostic importance of VEA dudeg exercise and 
recovery, when reactivation of parasympathetic activity occurs. We hypothesized that 
VEA dudng recovery would predict death better than VEA during exemise. 
Methods: We followed for 5.3 years 28,976 patients (age 56+11, 70% male) who under- 
went treadmill exercise testing and were without heart failure, valve disease, atrial fibdlla- 
tion, VEA history, or pacemakers. VEA was defined as: > 7 VPCs/minuta, ventricular 
bigeminy or trigeminy, ventricular tachycardia, or veetricular fibdllation. 
Results: VEA during exercise only occurred in 923 patients (3%), during recovery only in 
577 (2%), and during exercise and recovery in 483 (2%). There were 1801 deaths (6%). 
In univariate analyses, VEA dudng exercise predicted death (11% vs. 6%, hazard ratio 
[HR] 1.9, 95% CI 1.6-2.2, P<0.0001), but VEA during recovery was a stronger predictor 
(13% vs. 6%, HR 2.4, 95% CI 2.1-2.9, P<0.0001) (Figure), 
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